Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $505.76M.
ENTERPRISE VALUE (EV)
$505.76M
Helus Pharma Inc.
Market Cap
$663.54M
Enterprise Value (EV)
$505.76M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Helus Pharma Inc. (HELP) | $663.54M | $505.76M |
| MiMedx Group, Inc. (MDXG)vs › | $662.64M | $528.30M |
| Annexon, Inc. (ANNX)vs › | $671.12M | $496.50M |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $651.36M | $620.21M |
| OmniAb, Inc. (OABI)vs › | $637.15M | $631.73M |
| Aura Biosciences, Inc. (AURA)vs › | $634.58M | $583.34M |
| Anteris Technologies Global Corp. (AVR)vs › | $689.86M | $435.80M |
| Faeth Therapeutics, Inc. (FTH)vs › | $690.61M | $664.30M |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $697.00M | $649.06M |
| Climb Bio, Inc. (CLYM)vs › | $625.88M | $583.09M |
Market Cap
$663.54M
Total Debt
$0.00
Cash
$157.78M
Enterprise Value
$505.76M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
